Submit a manuscript Sign up for article alerts Contact us Support

About JOMT

This page includes information about the aims and scope of JOMT, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.

Aims & scope

JOMT is an open access, peer-reviewed, online journal that considers original research related to the field of occupational medicine and toxicology.

JOMT is aimed at clinicians and researchers in the wide-ranging discipline of occupational medicine and toxicology. The field is devoted to the diagnosis, prevention, management and scientific analysis of occupational diseases, injuries and disability; it also covers the promotion of health of workers, their families, and communities.

In the era of heavy industries, occupational medicine was known as "industrial medicine" with a focus on acute medical care for injured employees. The complexity of modern industrial processes has changed the field and today the areas covered by occupational medicine include effects of atmospheric pollution, carcinogenesis, biological monitoring, ergonomics, epidemiology, product safety, and health promotion.

The field of occupational medicine and toxicology is not static and the demand for studies addressing the large variety of current issues continues to grow. In view of this demand and the fact that the majority of occupational medicine and toxicology studies are currently published by journals of related fields such as pulmonary medicine, oncology or allergy, there is a need for a high-quality journal in this field. JOMT aims to provide this, with the important features of being an open access journal with an open peer review policy, and rapid publication process without major space limitations.

Open access

All articles published by JOMT are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

Authors of articles published in JOMT are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.

For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article-processing charges

Open access publishing is not without costs. JOMT therefore levies an article-processing charge of £1245/$2120/€1575 for each article accepted for publication. If the submitting author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.

Indexing services

All articles published in JOMT are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in JOMT include:

  • CABI
  • CAS
  • Citebase
  • DOAJ
  • Embase
  • EmBiology
  • Global Health
  • Google Scholar
  • Index Copernicus
  • OAIster
  • PubMed
  • PubMed Central
  • Science Citation Index Expanded
  • SCImago
  • Scopus
  • SOCOLAR
  • Zetoc

The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).

The full text of all research articles published by BioMed Central is also available on SpringerLink.

JOMT is tracked by Thomson Reuters (ISI) and has an Impact Factor of 1.23.

Publication and peer review process

Criteria for publication

JOMT considers the following types of articles:

  • Research - reports of data from original research.
  • Reviews - comprehensive, authoritative descriptions of any subject within the scope of JOMT. These articles are usually written by opinion leaders that have been invited by the Editorial Board.
  • Short reports - brief reports of data from original research.
  • Methodology articles - present a new experimental method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method.
  • Case reports - reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction.
  • Commentaries - short, focused and opinionated articles on any subject within the scope of the journal. These articles are usually related to a contemporary issue, such as recent research findings, and are often written by opinion leaders invited by the Editorial Board. These should be limited to 1000 words in length.
  • Debate articles - present an argument that is not essentially based on practical research. Debate articles can report on all aspects of the subject including sociological and ethical aspects.
  • Hypothesis - short articles presenting an untested original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable.
  • Software articles - describe the source code for software applications, tools or algorithm implementations.
  • Study protocols - describe proposed or ongoing research, providing a detailed account of the hypothesis, rationale, and methodology of the study.

Peer-review policies

JOMT has a closed peer review policy. Submitted manuscripts will be reviewed by two experts with the aim of reaching a decision as soon as possible. Reviewers are asked to declare any competing interests.

Edited by Axel Fischer and David A Groneberg, JOMT is supported by an expert Editorial Board.

Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Journal of Occupational Medicine and Toxicology, a personalized section of the site.

Reprints

High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.

Supplements

JOMT will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.

Editorial policies

All manuscripts submitted to JOMT should adhere to BioMed Central's editorial policies.

Citing articles in JOMT

Articles in JOMT should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. J Occup Med Toxicol [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. J Occup Med Toxicol 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Why publish your article in JOMT?

High visibility

JOMT's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.

Speed of publication

JOMT offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through JOMT, BioMed Central and PubMed Central and will also be included in PubMed.

Flexibility

Online publication in JOMT gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in JOMT are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on JOMT's pages and on the BioMed Central homepage.

In addition, articles published in JOMT may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in JOMT. A list of articles recently press-released by journals published by BioMed Central is available here.

Authors of articles published in JOMT retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.